Pura Vida Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-28,200
Closed -$6.77M 103
2023
Q2
$6.77M Buy
+28,200
New +$5.86M 0.9% 35
2022
Q4
Sell
-75,000
Closed -$11.8M 225
2022
Q3
$11.8M Buy
75,000
+5,000
+7% +$798K 0.68% 45
2022
Q2
$10.5M Buy
70,000
+40,000
+133% +$5.79M 0.61% 45
2022
Q1
$4.91M Sell
30,000
-6,800
-18% -$1.12M 0.16% 124
2021
Q4
$8.01M Sell
36,800
-500
-1% -$105K 0.29% 86
2021
Q3
$7.06M Buy
+37,300
New +$6.8M 0.21% 122

Other funds holding MEDP

Pura Vida Investments's MEDP Position: Q1 2018 in Review

Pura Vida Investments sold out of Medpace (MEDP) in Q1 2018, closing a stake of 70,000 shares — an estimated $2.54M sold.

Pura Vida Investments first reported a position in MEDP in Q3 2016 and held it in 4 quarters. The position peaked at $4.73M in Q3 2016. 113 funds tracked by Wall St. Rank hold MEDP as of Q1 2018.

  • Pura Vida Investments reported no remaining Medpace position as of Q1 2018 after selling out during the quarter.
  • Pura Vida Investments sold 70,000 Medpace shares in Q1 2018, an estimated $2.54M.
  • Pura Vida Investments first reported a position in Medpace in Q3 2016 and held it in 4 quarters.
  • Pura Vida Investments's Medpace position peaked at $4.73M in Q3 2016.
  • 113 funds tracked by Wall St. Rank held Medpace as of Q1 2018.

Based on Pura Vida Investments's 13F filing for Q1 2018, filed 14 May 2018.